Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PD-2 Activators

PD-2 Activators are a selective group of chemical compounds that enhance the functional activity of PD-2 through modulation ofspecific signaling pathways and cellular processes. Forskolin and 8-Bromo-cAMP, by increasing intracellular cAMP levels, indirectly enhance PD-2's functional activity via PKA activation, which may phosphorylate PD-2 or modulate processes in which PD-2 is involved. Similarly, Dibutyryl cAMP acts as a stable cAMP analog, targeting the same PKA-dependent pathways to potentially enhance PD-2 activity. Sildenafil, by inhibiting PDE5, increases cGMP levels, thereby activating PKG pathways that could intersect with PD-2's regulatory mechanisms. Phorbol 12-myristate 13-acetate (PMA) activates Protein Kinase C (PKC), and if PD-2 is a substrate or modulated by PKC, PMA would enhance its activity. Ionomycin, through increased intracellular calcium, could activate calcium-dependent pathways that regulate PD-2, while Epigallocatechin gallate (EGCG) may lift inhibitory kinase regulation on PD-2, thereby enhancing its activity.

Further indirect modulation of PD-2 activity is achieved through compounds that influence the MAPK and PI3K/Akt pathways. LY294002, a PI3K inhibitor, could shift cellular signaling to favor PD-2's function if PD-2 is associated with the PI3K/Akt pathway. SB203580 and U0126, which inhibit p38 MAPK and MEK1/2 respectively, could redirect signaling to enhance PD-2 activity if PD-2 is involved in signaling cascades usually restrained by these kinases. AICAR, an AMPK activator, suggests potential enhancement of PD-2 function through AMPK-regulated pathways. ZM-447439's role as an Aurora kinase inhibitor implies that if PD-2's activity is suppressed by Aurora kinases, its inhibition would lead to an enhancement of PD-2's function. Collectively, these compounds, through their targeted effects on distinct signaling pathways, offer a comprehensive approach to enhancing the functional activity of PD-2 without necessitating changes in gene expression or direct activation of the protein.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA functions as a diacylglycerol analog, activating protein kinase C (PKC). If PD-2 is a substrate of PKC or is regulated by PKC-mediated signaling, PMA would enhance PD-2's functional activity through the PKC pathway.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which may then phosphorylate PD-2 or modulate its activity if PD-2 is part of a cAMP-dependent pathway.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels. If PD-2's function is calcium-dependent, ionomycin would indirectly enhance PD-2 activity by raising intracellular calcium concentrations.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a polyphenol that can inhibit certain protein kinases. If PD-2's activity is negatively regulated by a kinase that EGCG inhibits, then EGCG may enhance PD-2 activity by lifting this inhibition.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

8-Bromo-cAMP is a cell-permeable cAMP analog. It activates PKA, and if PD-2 is regulated by PKA-mediated phosphorylation, 8-Bromo-cAMP could enhance PD-2 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. If PD-2 operates downstream of PI3K or within PI3K-regulated pathways, inhibiting PI3K could shift cellular signaling in favor of enhancing PD-2's activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor. If PD-2 is part of a signaling cascade that is normally inhibited by p38 MAPK, then inhibition of this kinase could result in the enhancement of PD-2 activity.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AICAR activates AMPK, and if PD-2 activity is enhanced by AMPK signaling or if PD-2 interacts with pathways controlled by AMPK, AICAR could indirectly enhance PD-2's functional activity.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

ZM-447439 is an Aurora kinase inhibitor. If PD-2's activity is suppressed by Aurora kinases, its inhibition could lead to the enhancement of PD-2's function.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl cAMP is a stable cAMP analog that activates PKA. If PD-2 is regulated through PKA-dependent phosphorylation, this compound could enhance PD-2's activity.